The agency refuses to disclose the names of the drugs it is reassessing, on the grounds that doing so would expose "confidential commercial information." But here are five drugs that used the controversial tests to help win FDA approval.
Discovered: the Orion Nebula doesn't have that many stars; naked mole-rats are ugly because of evolution; recapping the Ig Nobel Prize ceremony; doctors wary of drug company findings.
For good or bad, a recently published email exchange between the White House and Big Pharma during the height of the 2009 health care reform debate, is one of the most important documents from that epic legislative struggle.
Diplomats work hard to protect the profits of drug makers
A harder-to-abuse version of Oxycodone could be on shelves by year end
'Eternal Sunshine of the Spotless Mind' inches ever closer to reality
Have a story we missed? A link we have to click? A sharp opinion about the news? Instead of waiting for us to post it, tell us on the Open Wire.
Submit your news and ideas | See all reader postsThe Atlantic Wire is your authoritative guide to the news and ideas that matter most right now. Our team tracks newsmakers and opinions across the entire media spectrum: newspapers, web sites, television, radio and magazines.
But we do more than just collect information. By synthesizing, analyzing and summarizing what’s out there, and adding new information when we can, we are a news engine that gives you a quick and valuable account of the issues of the day.
Have a hot tip? A story we missed? Tell us on the Open Wire
How to send us editorial or technical feedback
Get Five Best Columns in your inbox each morning (preview)
